This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
He had me at the statement, “I believe healthdata is medicine.”. Those were the words of Ardy Arianpour, CEO and Co-Founder of Seqster, when sharing with me how his company was founded. In summing up the patient-centered interoperability goal, Ardy summarized: “We’ve created the Mint.com of healthdata.”
These technologies are emerging from both the medical-tech developers as well as consumer-grade and -facing companies: think HIMSS and RSNA vis-a-vis CES/the Consumer Technology Association. How to protect vulnerable groups of people? How to ensure that devices are meant for well-being and not exploitation?
Most younger physicians saw positive effects of using technology during the pandemic, bolstering their interest in remaining in medicine. country findings, note that 93% of younger doctors were unable to fully leverage healthdata to its full potential in their workflow during the pandemic. In the second chart on U.S.
But while the new ONC rules may make it easier for health consumers to access personal health information, the Field of Dreams phenomenon subverts the noble goal: we may “build” a system for people to access healthdata (like Blue Button), but patients may not “come.” How to deal?
Tom explains, so accessibly and with evidence, how AI and the intelligent cloud can help us address a range of big challenges in health care. Importantly and impactfully, he details how to move from aspiration to execution. And you get a bonus: a Foreword written by Eric J. Topol, MD, of Scripps Research.
Data literacy, the ability to comprehensive one’s “numbers” displayed in lab test results and other patient-facing clinical communications. Medical literacy, such as understanding medical instructions following up procedures, lab tests, and inpatient discharges to the home.
Healthcare providers, researchers, pharmaceutical companies, and medicaltechnology specialists will all need to take a phased approach to deploying new technologies. Leaders should begin evaluating how to put the right strategies in place and commit to continuous innovation.
Additionally, RPM fosters greater patient engagement in their own care by providing them with access to their healthdata and empowering them to actively participate in managing their condition alongside their healthcare team. Educating patients Effective patient education is essential for ensuring successful RPM adoption.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content